Business Name: |
Sun Pharmaceutical Industries |
Contact Person: |
Jitendra Doshi, Executive Director |
Address: |
270 Prospect Plains Road, Cranbury, New Jersey 08512 |
Phone Number: |
(609) 495-2800 |
Website Address: |
sunpharma.com |
Annual Revenue (USD): |
$20.000.000 to $49.9999.999 |
Founding Year: |
2004 |
Location Type: |
Branch |
Employee Number: |
1 to 4 |
Business Type: |
B2B & B2C |
Business Category: |
|
SIC Code: |
2834 |
NAICS Code: |
3254120 |
Share This Business: |
|
Related Businesses: |
The Frederick Purdue Company - Cranbury, NJ 08512 Evenus Pharmaceutical Labs Inc - Cranbury, NJ 08512 Endo Pharmaceuticals Solutions Inc - Cranbury, NJ 08512 Cmic Cmo Usa Corporation - Cranbury, NJ 08512 Purdue Pharma Lp - Cranbury, NJ 08512 Endo Pharmaceuticals Inc - Cranbury, NJ 08512 Palatin Technologies Inc - Cranbury, NJ 08512 Moore Family Realty Inc - Cranbury, NJ 08512 Kos Pharmaceuticals Inc - Cranbury, NJ 08512 Wyeth LLC - Cranbury, NJ 08512 Amicus Therapeutics Inc - Cranbury, NJ 08512 Cocensys Inc - Cranbury, NJ 08512 Pharmacopeia Inc - Cranbury, NJ 08512 Caraco Pharmaceutical Laboratories Ltd - Cranbury, NJ 08512 P F Laboratories Inc - Cranbury, NJ 08512 Evenus Pharmaceutical Laboratories Inc - Cranbury, NJ 08512 |
The company Sun Pharmaceutical Industries provides BOTH services in the form of from its branch in New Jersey.
1 to 4 employees work for Sun Pharmaceutical Industries, and the business now earns $20.000.000 to $49.9999.999 per annum.
Sun Pharmaceutical Industries was launched in 2004 and is classified under SIC code and category 2834 , and NAICS number and grouping 3254120 .
To contact Sun Pharmaceutical Industries, please call Jitendra Doshi, Executive Director with the phone number (609) 495-2800 or visit its branch at 270 Prospect Plains Road in Cranbury, New Jersey 08512.
The location of the branch can also be found using the coordinates 40.32727,-74.4861.
Read more details about this business on the webpage sunpharma.com or follow the company’s social media accounts, on Twitter and on Facebook.